Blood testing device will boost IDS sales; Taking Stock.Byline: Christopher Knox A MEDICAL testing company is entering what it believes will the biggest growth spurt growth spurt Pediatrics A period of rapid growth in middle adolescence; ♀ ↑ ±8 cm/yr ±age 12; ♂ ↑ ±10 cm/yr ± age 14; GS is orderly, affecting acral parts–ie, hands and feet grow before proximal regions, in its history after launching an automated version of its blood testing device. Immunodiagnostic immunodiagnostic pertaining to diagnosis by immune reactions. Systems (IDS), based in Boldon, South Tyneside South Tyneside is a metropolitan borough in Tyne and Wear in North East England. It is bordered by four other boroughs - Newcastle upon Tyne and Gateshead to the west, Sunderland in the south, and North Tyneside to the north. , believes its sales will be "significantly" increased after releasing the IDS iSYS device, which allows doctors to test blood with the touch of a button. The device has also been released alongside a vitamin D vitamin D Any of a group of fat-soluble alcohols important in calcium metabolism in animals to form strong bones and teeth and prevent rickets and osteoporosis. It is formed by ultraviolet radiation (sunlight) of sterols (see steroid) present in the skin. assay, which tests whether patients are deficient in the vitamin leading to the development of a number of conditions, including cancer. The demand for an automated product has been fuelled by greater understanding of the importance of vitamin D in helping to fend off such diseases as well as its involvement in building strong bones and teeth. Analysts now predict that the launch will see the AIM-listed company increase its turnover from pounds 18.7m to just under pounds 30m by next year as demand for vitamin D testing grows and the process moves closer towards being 100% automated. IDS chief executive Dr Roger Duggan said: "The launch of the IDS iSYS represents a major milestone in the company's history. "Automation of our highly specialised diagnostic products will take us into much larger and more prestigious clinical and corporate laboratories, accounts that we were hitherto beyond our reach." The firm, which was set up in 1981, was able to give the technology a final push after raising pounds 3.1m in December through a share issue, which it added to the pounds 4m it received from the sale of its haematology business to US firm Escalon Medical Corporation. The firm, which employs 75 staff between its sites in the UK, Germany, the US and Scandinavia, is now hoping to see its turnover rocket in line with analysts Daniel Stewart General Daniel Stewart (December 20, 1761 - May 27, 1829) was a brigadier general in the Georgia Militia. He joined the militia in 1776 and served during the American Revolutionary War and the War of 1812.[1] Stewart was the great-grandfather of Theodore Roosevelt. and Company's (DS&C) projected leap from pounds 19m to pounds 25.3m this year when it reports in June. Vadim Alexandre, equity analyst at DS&C, said: "Through the launch of its new mechanised platform, the group is now entering the fully automated assays market. Full automation of the assay process allows for far greater volumes of samples to be tested while reducing staff numbers." |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion